| abstract |
In patients with chronic kidney disease, lower and / or control serum phosphorus levels, increase serum bicarbonate levels, improve one or more iron storage parameters (e.g., increase serum ferritin levels, transferrin saturation ( Increase TSAT), increase hemoglobin concentration), increase iron absorption, maintain iron storage, treat iron deficiency, treat anemia, reduce IV iron need, and / or erythropoiesis To reduce the need for stimulants (ESA), a method of administering ferric citrate is disclosed. [Selection figure] None |